NEW YORK (GenomeWeb News) – Life Technologies will distribute Aruna Biomedical's human embryonic stem cell-derived neural products, under a non-exclusive, multi-year agreement announced today by Athens, Ga.-based Aruna.
Aruna said that Life Technologies will provide the neural products and will be able to provide customized screening services using Aruna products and technologies. The firm said that other human cellular products may be added to the pact in the future.
Steve Stice, chief scientific officer for Aruna, said that Life Technologies "has a broad reach to both domestic and global markets which we expect will lead to more opportunities for our stem cell products."
Financial and other terms of the deal were not disclosed.